- Pyrantel tartrate
-
- $34.00
-
2026-04-22
- CAS:33401-94-4
- Purity: 99.96%
- Supply Ability: 10g
- Pyrantel tartrate
-
- $34.00
-
2026-04-22
- CAS:33401-94-4
- Purity: 99.96%
- Supply Ability: 10g
- PYRANTEL TARTRATE SALT
-
- $1.10
-
2025-06-25
- CAS:33401-94-4
- Min. Order: 1g
- Purity: 99.0% min
- Supply Ability: 100 tons min
|
| | PYRANTEL TARTRATE SALT Basic information |
| Product Name: | PYRANTEL TARTRATE SALT | | Synonyms: | 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)-pyrimidin(e)-pyrimidintartrate;cp10423-18;pyrantel hydrogen tartrate;Pyrantel Tartate;(E)-4,5,6-TETRAHYDRO-1-METHYL-2-(2-(2-THIENYL)ETHENYL)PYRIMIDINE;(E)-1,4,5,6-Tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine tartrate (1:1);PYRANTEL TARTRATE SALT;Pyrantel (+)-tartrate salt,1-Methyl-2-(2-[2-thienyl]ethenyl)-1,4,5,6-tetrahydropyrimidine | | CAS: | 33401-94-4 | | MF: | C15H20N2O6S | | MW: | 356.39 | | EINECS: | 251-501-8 | | Product Categories: | | | Mol File: | 33401-94-4.mol |  |
| | PYRANTEL TARTRATE SALT Chemical Properties |
| Melting point | 148-150° | | storage temp. | Inert atmosphere,Room Temperature | | solubility | H2O: soluble4.0ML, clear, colorless to faint yellow or tan (Solvent: 200 mg plus 4.0 mL ) | | form | Solid | | color | Light yellow to yellow | | Major Application | pharmaceutical (small molecule) | | InChI | 1S/C11H14N2S.C4H6O6/c1-13-8-3-7-12-11(13)6-5-10-4-2-9-14-10;5-1(3(7)8)2(6)4(9)10/h2,4-6,9H,3,7-8H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/b6-5+;/t;1-,2-/m.1/s1 | | InChIKey | VWRCYAZJKNPEQR-NIEARKAZSA-N | | SMILES | O[C@H]([C@@H](O)C(O)=O)C(O)=O.CN1CCCN=C1\C=C\c2cccs2 |
| Hazard Codes | T | | Risk Statements | 25 | | Safety Statements | 45 | | RIDADR | UN 2811 6.1/PG 3 | | WGK Germany | 3 | | RTECS | UW0249000 | | HazardClass | 6.1(b) | | PackingGroup | III | | HS Code | 2934990002 | | Storage Class | 6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects | | Hazard Classifications | Acute Tox. 3 Oral | | Toxicity | cattle,LD,unreported,> 200mg/kg (200mg/kg),Australian Veterinary Journal. Vol. 46, Pg. 297, 1970. |
| | PYRANTEL TARTRATE SALT Usage And Synthesis |
| Uses | Anthelmintic;Neuromuscular depolarizing agent | | Brand name | Banminth (Pfizer). | | Safety Profile | Poison by ingestion and intravenous routes. When heated to decomposition it emits very toxic fumes of NOx and SOx. | | in vivo | Pyrantel tartrate (10 mg/kg; p.o.; single) reduces the worms in A. ceylanicum-infected hamsters, with the worm burden reduction of 87.2% and worm expulsion rate of 63.4%[2]. | Animal Model: | Male Syrian Golden hamsters (3-week-old; A. ceylanicum-infected)[2]. | | Dosage: | 10 mg/kg | | Administration: | Oral administration; single. | | Result: | Exhibited worm burden reduction and worm expulsion rates of 87.2% and 63.4%, respectively. |
|
| | PYRANTEL TARTRATE SALT Preparation Products And Raw materials |
|